During the quarter ended December 31, 2025, Runway Growth generated total investment income of $30.0 million and net investment income of $11.6 million, or $0.32 per share. Dollar-weighted annualized yield on debt investments was 14.2%, while net asset value stood at $485.0 million, or $13.42 per share.

For the full year, Runway Growth recorded total investment income of $137.3 million and net investment income of $56.9 million, or $1.55 per share, on an investment portfolio valued at $927.4 million at fair value. Aggregate fundings totaled $261.6 million across new and existing portfolio companies, with minimal credit losses averaging 10 basis points gross.

As of December 31, 2025, the company held 56 portfolio companies with $860.3 million in loans and $67.1 million in equity-related investments. During Q4 it funded $42.9 million across seven transactions, received $75.6 million in principal prepayments and sale proceeds, and declared a first-quarter 2026 dividend of $0.33 per share.

Runway Growth anticipates closing its proposed acquisition of SWK Holdings to expand its healthcare and life sciences exposure, leveraging the BC Partners Credit platform to widen origination channels. Management remains confident in disciplined capital deployment, supported by a robust pipeline.